RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

NYSE Euronext, Inc.

A collection of news and information related to NYSE Euronext, Inc. published by this site and its partners.

Top NYSE Euronext, Inc. Articles see all

Displaying items 1-5
  • BofA reports first quarterly loss since 2011 on lofty legal bill

    (Reuters) - Bank of America Corp reported an unexpected first-quarter loss on Wednesday after it took a $6 billion charge to cover litigation expenses, a figure that far exceeded the legal settlements the No. 2 U.S. bank has announced recently.
  • Abbott Laboratories profit beats forecast, but sales lag

    (Reuters) - Abbott Laboratories Inc reported better-than-expected quarterly earnings on Wednesday, but combined sales of its nutritional products, medical devices and generic medicines were slightly below Wall Street expectations. The company earned $375...

    NBA? Kevin Ollie Tells Gayle King, 'Not Now ... But Never Say Never'

    NBA? Kevin Ollie Tells Gayle King, 'Not Now ... But Never Say Never'
    Kevin Ollie was interviewed on CBS This Morning Wednesday by Gayle King. He covered a lot of territory he has already covered recently, but he did address the prospects of coaching in the NBA, appearing to close the door on it now, but not in the future....

    FDA OKs new generation Boston Scientific heart pacing devices

    (Reuters) - U.S. health regulators have approved four Boston Scientific Corp implantable devices for heart patients, including a next generation of smaller defibrillators to treat abnormal heart rhythms, the company said on Tuesday. The Food and Drug...

    J&J beats forecasts as sales of new drugs shine

    (Reuters) - Johnson & Johnson reported quarterly earnings well above expectations, as strong sales of new drugs offset weak demand for consumer products and medical devices, and the company slightly raised its full-year profit view. J&J on Tuesday said...